Literature DB >> 11886980

Successful treatment of refractory mononeuritis multiplex secondary to rheumatoid arthritis with the anti-tumour necrosis factor alpha monoclonal antibody infliximab.

C Garcia-Porrua, M A González-Gay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11886980     DOI： 10.1093/rheumatology/41.2.234

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  4 in total

Review 1.  Rheumatoid vasculitis: vanishing menace or target for new treatments?

Authors:  Christie M Bartels; Alan J Bridges
Journal:  Curr Rheumatol Rep       Date:  2010-12       Impact factor: 4.592

2.  Improved rheumatoid digital vasculitis in a patient treated with TNFalpha agent blocking (infliximab).

Authors:  Maurizio Benucci; Francesca Li Gobbi; Gianantonio Saviola; Mariangela Manfredi
Journal:  Rheumatol Int       Date:  2008-05-21       Impact factor: 2.631

Review 3.  Indications for biotherapy in systemic vasculitides.

Authors:  Loïc Guillevin; Christian Pagnoux; Philippe Guilpain; Boris Bienvenu; Valérie Martinez; Luc Mouthon
Journal:  Clin Rev Allergy Immunol       Date:  2007-02       Impact factor: 10.817

4.  Digital vasculitis in a patient with rheumatoid arthritis responded well to adalimumab.

Authors:  Senol Kobak; Hatice Yilmaz; Murat Yalcin; Ahmet Karaarslan
Journal:  Case Rep Rheumatol       Date:  2014-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.